Catching breath: monitoring airway inflammation using exhaled breath condensate Holz O. Eur Respir J 2005; 26: 371-372 | |
Eradication therapy for early Pseudomonas aeruginosa infection in CF: many questions still unanswered Jones A. M. Eur Respir J 2005; 26: 373-375 | |
Is this the beginning of unravelling the puzzle of COPD exacerbations? Rodriguez-Roisin R. Eur Respir J 2005; 26: 376-378 | |
Yes to NO: the first studies on exhaled nitric oxide-driven asthma treatment de Jongste J. C. Eur Respir J 2005; 26: 379-381 | |
-308GA and TNFB polymorphisms in acute respiratory distress syndrome Gong M. N., Zhou W., Williams P. L., Thompson B. T., Pothier L., Boyce P., Christiani D. C. Eur Respir J 2005; 26: 382-389 | |
Skeletal muscle inflammation and nitric oxide in patients with COPD Montes de Oca M., Torres S. H., De Sanctis J., Mata A., Hernandez N., Talamo C. Eur Respir J 2005; 26: 390-397 | |
Does leptin play a cytokine-like role within the airways of COPD patients? Bruno A., Chanez P., Chiappara G., Siena L., Giammanco S., Gjomarkaj M., Bonsignore G., Bousquet J., Vignola A. M. Eur Respir J 2005; 26: 398-405 | |
Relationship between respiratory symptoms and medical treatment in exacerbations of COPD Calverley P., Pauwels{dagger} R., Lofdahl C-G., Svensson K., Higenbottam T., Carlsson L-G., Stahl E. Eur Respir J 2005; 26: 406-413 | |
Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression Gudmundsson G., Gislason T., Janson C., Lindberg E., Hallin R., Ulrik C. S., Brondum E., Nieminen M. M., Aine T., Bakke P. Eur Respir J 2005; 26: 414-419 | |
Physiological changes during symptom recovery from moderate exacerbations of COPD Parker C. M., Voduc N., Aaron S. D., Webb K. A., O'Donnell D. E. Eur Respir J 2005; 26: 420-428 | |
Time to death, airway wall inflammation and remodelling in fatal asthma James A. L., Elliot J. G., Abramson M. J., Walters E. H. Eur Respir J 2005; 26: 429-434 | |
Asthma self-management skills and the use of asthma education during pregnancy Murphy V. E., Gibson P. G., Talbot P. I., Kessell C. G., Clifton V. L. Eur Respir J 2005; 26: 435-441 | |
Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor Casas A., Gomez F. P., Dahlen B., Roca J., Barbera J. A., Dahlen S-E., Rodriguez-Roisin R. Eur Respir J 2005; 26: 442-448 | |
Dietary intake of flavonoids and asthma in adults Garcia V., Arts I. C. W., Sterne J. A. C., Thompson R. L., Shaheen S. O. Eur Respir J 2005; 26: 449-452 | |
Nasal NO: normal values in children age 6 through to 17 years Struben V. M. D., Wieringa M. H., Mantingh C. J., Bommelje C., Don M., Feenstra L., de Jongste J. C. Eur Respir J 2005; 26: 453-457 | |
Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients Taccetti G., Campana S., Festini F., Mascherini M., Doring G. Eur Respir J 2005; 26: 458-461 | |
High hepatotoxicity of pyrazinamide and ethambutol for treatment of latent tuberculosis Younossian A. B., Rochat T., Ketterer J-P., Wacker J., Janssens J-P. Eur Respir J 2005; 26: 462-464 | |
Cost-effectiveness of isoniazid chemoprevention in close contacts Diel R., Nienhaus A., Schaberg T. Eur Respir J 2005; 26: 465-473 | |
A prediction rule for clinical diagnosis of severe acute respiratory syndrome Ho P. L., Chau P. H., Yip P. S. F., Ooi G. C., Khong P. L., Ho J. C., Wong P. C., Ko C., Yan C., Tsang K. W. Eur Respir J 2005; 26: 474-479 | |
Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer Moro-Sibilot D., Aubert A., Diab S., Lantuejoul S., Fourneret P., Brambilla E., Brambilla C., Brichon P. Y. Eur Respir J 2005; 26: 480-486 | |
The role of increased pulmonary blood flow in pulmonary arterial hypertension van Albada M. E., Schoemaker R. G., Kemna M. S., Cromme-Dijkhuis A. H., van Veghel R., Berger R. M. F. Eur Respir J 2005; 26: 487-493 | |
Respiratory function and self-reported functional health: EPIC-Norfolk population study Myint P. K., Luben R. N., Surtees P. G., Wainwright N. W. J., Welch A. A., Bingham S. A., Wareham N. J., Day N. E., Khaw K-T. Eur Respir J 2005; 26: 494-502 | |
Tuberculosis treatment outcomes in Europe: a systematic review Faustini A., Hall A. J., Perucci C. A. Eur Respir J 2005; 26: 503-510 | |
Standardisation of the measurement of lung volumes Wanger J., Clausen J. L., Coates A., Pedersen O. F., Brusasco V., Burgos F., Casaburi R., Crapo R., Enright P., van der Grinten C. P. M., Gustafsson P., Hankinson J., Jensen R., Johnson D., MacIntyre N., McKay R., Miller M. R., Navajas D., Pellegrino R., Eur Respir J 2005; 26: 511-522 | |
Exhaled breath condensate: methodological recommendations and unresolved questions Horvath I., Hunt J., Barnes P. J., On behalf of the ... Eur Respir J 2005; 26: 523-548 | |
Recurrent sarcoid granulomas in a transplanted lung derive from recipient immune cells Milman N., Andersen C. B., Burton C. M., Iversen M. Eur Respir J 2005; 26: 549-552 | |
Tuberculosis mimicry Tay N. S. W. T., Ong K. C., Tan S. Y., Kaw G. J. L. Eur Respir J 2005; 26: 554-556 | |
Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis Koh W-J., Kwon O. J., Park Y. K., Lew W. J., Bai G. H. Eur Respir J 2005; 26: 557 | |
Should we use spirometry in the early detection of COPD? White P. Eur Respir J 2005; 26: 558-559 | |
From the author Enright P. Eur Respir J 2005; 26: 559 | |